A new study led by Western researchers found frequent treatment with intranasal oxytocin—a hormone in the brain associated with empathy—offers promise for addressing a key symptom among patients with frontotemporal dementia (FTD): Apathy.
A new study led by Western researchers found frequent treatment with intranasal oxytocin—a hormone in the brain associated with empathy—offers promise for addressing a key symptom among patients with frontotemporal dementia (FTD): Apathy.